Universitätsklinik für Kardiologie
 
Menü
 
Universitätsklinik für Kardiologie / Mitarbeiter
 
 
Dr. med. Enno Boudriot / Publikationen
 
2016
 
Uhlemann M, Möbius-Winkler S, Adam J, Erbs S, Mangner N, Sandri M, Boudriot E, Woinke M, Schuler GC, Linke A
The Leipzig Prospective Drug-Eluting Balloon-Registry- Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons.
Circ J. 2016 Jan 25;80(2):379-86
 
Desch S, Stiermaier T, de Waha S, Lurz P, Gutberlet M, Sandri M, Mangner N, Boudriot E, Woinke M, Erbs S, Schuler G, Fürnau G, Eitel I, Thiele H
Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset.
JACC Cardiovasc Interv. 2016 Jan 25;9(2):113-22
 
Majunke N, Mangner N, Linke A, Boudriot E, Erbs S, Tietz F, Wolff S, Schurer S, Schuler G, Sandri M
Comparison of Percutaneous Closure Versus Surgical Femoral Cutdown for Decannulation of Large-Sized Arterial and Venous Access Sites in Adults After Successful Weaning of Veno-Arterial Extracorporeal Membrane Oxygenation.
J Invasive Cardiol 2016; 28(10): 415-419
ISSN 1042-3931
 
Uhlemann M, Mobius-Winkler S, Adam J, Erbs S, Mangner N, Sandri M, Boudriot E, Woinke M, Schuler GC, Linke A
The Leipzig Prospective Drug-Eluting Balloon-Registry - Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons.
Circ J 2016; 80(2): 379-386
ISSN 1346-9843
 
Desch S, Stiermaier T, de Waha S, Lurz P, Gutberlet M, Sandri M, Mangner N, Boudriot E, Woinke M, Erbs S, Schuler G, Fuernau G, Eitel I, Thiele H
Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset.
JACC Cardiovasc Interv 2016; 9(2): 113-122
ISSN 1936-8798
 
 
2015
 
Eitel I, Stiermaier T, Rommel KP, F├╝rnau G, Sandri M, Mangner N, Linke A, Erbs S, Lurz P, Boudriot E, Mende M, Desch S, Schuler G, Thiele H
Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial.
Eur Heart J 2015; 36(44): 3049-3057
ISSN 0195-668X
 
 
2014
 
Stiermaier T, Heinz A, Schloma D, Kleinertz K, Danschel W, Erbs S, Linke A, Boudriot E, Lauer B, Schuler G, Thiele H, Desch S
Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial).
Catheter Cardiovasc Interv 2014; 83(3): 418-424
 
 
2013
 
Desch S, Boudriot E, Rastan A, Buszman PE, Bochenek A, Mohr FW, Schuler G, Thiele H
Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease. A meta-analysis of randomized controlled trials.
Herz 2013; 38(1): 48-56
 
Stiermaier T, Schuler G, Boudriot E, Desch S, Thiele H
Is percutaneous coronary intervention as effective as bypass surgery in left main stem coronary artery stenosis?
Herz 2013; 38(2): 147-152
 
 
2011-2001
 
Boudriot E, H Thiele, T Walther, C Liebetrau, P Boeckstegers, T Pohl, B Reichart, H Mudra, F Beier, B Gansera, FJ Neumann, M Gick, T Zietak, S Desch, G Schuler, FW Mohr: Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis. J Am Coll Cardiol 2011; 57: 538-45.
 
Boudriot E, Thiele H, Schuler G: Left main interventions. Options and limitations in interventional cardiology. Herz 2011; 36: 214-221.
 
Boudriot E: Kathetertypen, Katheterfunktionen. Diabetes & Technologie 2011 (2): 12-15
 
Boudriot E: Katheterbehandlung in der Gefäßmedizin. Diabetes & Technologie 2011 (2): 16-18
 
Boudriot E, Rastan A, Walther T, Thiele H, Desch S, Schuler G, Mohr FW: Revaskularisation bei 3-Gefäßerkrankung und Hauptstammstenosen. Klinikarzt 2009; 38 (12): 546-551.
 
Boudriot E, Schuler G, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Reichart B, Mudra H, Neumann FJ, Mohr FW: Unprotected left main stenosis: Multicenter randomized trial between CABG and PCI with Sirolimus eluting stent. Eur Heart J. 2009, 30 (supp.1): 462
 
Schäfer A, Arntz HR, Boudriot E, Garlichs C, Helms TM, Hoffmann S, Ince H, Weil J, Zugck C, Helms TM, Silber S: Differenzierte antithrombotische Therapie bei akutem Koronarsyndrom Dtsch Med Wochenschr 2013; 138: 1-7
 
Desch S, Boudriot E, Rastan A, Buszman PE, Bochenek A, Mohr FW, Thiele H, Schuler G: Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease: A meta-analysis of randomized controlled trials. Herz 2012; 37: ahead of print
 
Silber S, Helms TM, Garlichs C, Arntz HR, Weil J, Ince H, Klingenheben T, Hoffmann S, Boudriot E, Steiger H, Zugck C. Prasugrel for acute and long-term treatment of patients with acute coronary syndroms: what is state-of-the-art? Dtsch Med Wochenschr. 2011 Apr;136(15):782-5.
 
Beutner F, Teupser D, Gielen S, Holdt LM, Scholz M, Boudriot E, Schuler G, Thiery J: Rationale and design of the Leipzig (LIFE) heart study: Phenotyping and cardiovascular characteristics of patients with coronary artery disease. PLoS ONE 2011; 6(12) e29070
 
Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E, Walther T, Mohr FW, Schuler G: Randomized comparison of Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) surgery versus sirolimus-eluting stenting in isolated proximal LAD-stenosis. Eur Heart J. 2009; 30 (supp.1): 322
 
Rastan A, Boudriot E, Walther T, Falk V, Kappetein P, Serruys P, Doll N, Schuler G: Frequency and pattern of multivessel and left main coronary artery disease - Insights from a center specific SYNTAX study enrollment. Thoracic and Cardiovascular Surgeon 2007, 55
 
Rastan A, Boudriot E, Falk V, Kappetein A, Borger MA, Serruys PW, Schuler G, Mohr FW: Frequency and pattern of de-novo three-vessel and left main coronary artery disease - Insights from single center enrolment in the SYNTAX study. Eur J Cardiothorac Surg 2008; 34(2): 376-383
 
Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G: Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; Jul;26(13):1276-83
 
Thiele H, Kappl MJ, Linke A, Erbs S, Boudriot E, Lembcke A, Kivelitz D, Schuler G: Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging. Eur Heart J 2007 Jun;28(12):1433-9
 
Thiele H, Engelmann L, Elsner K, Storch WH, Rahimi K, Hartmann M, Pfeiffer D, Boudriot E, Kappl M, Schuler G: Prehospital thrombolytic/abciximab therapy in comparison to facilitated percutaneous coronary intervention after combined prehospital thrombolysis in myocardial infarction. J Am Coll Cardiol 2003; 41(6): 332
 
Thiele H, Lauer B, Hambrecht R, Boudriot E, Sick P, Niebauer J, Falk V, Schuler G: Short- and long-term hemodynamic effects of intra-aortic balloon support in ventricular septal defect complicating acute myocardial infarction. Am J Cardiol 2003; 92(4): 450-4
 
Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G: Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001; 104(24): 2917-22
 
 
Universitätsklinik für Kardiologie / Enno Boudriot
Bild
 
 
Universitätsklinik für Kardiologie